03/30/2011 - 10:18am

Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.

03/29/2011 - 11:35am

For many patients, the inability to pay for drugs is enough of a problem, but what if the drugs they need aren’t available at all?

03/25/2011 - 3:04pm

A group representing specialty pharmacies is calling on the Department of Defense to not use exclusive networks in the Tricare pharmacy program.

03/25/2011 - 12:48pm

The Food and Drug Administration has approved a new treatment for late-stage skin cancer, the agency said Friday.

03/25/2011 - 11:14am

"Dispense-as-written" prescriptions are exacerbating medication nonadherence and costing the U.S. healthcare system billions of dollars, according to a new study by researchers at Harvard University, Brigham and Women's Hospital, and CVS Caremark.

03/24/2011 - 1:01pm

The Food and Drug Administration has extended its regulatory review period for Novartis' new drug application for its once-daily, long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, as well as chronic bronchitis and/or emphysema, the drug maker said.

03/24/2011 - 12:54pm

Bristol-Myers Squibb said its late-stage clinical trial for a cancer treatment, which currently is under review by the Food and Drug Administration, achieved its primary endpoint.

03/24/2011 - 12:47pm

GlaxoSmithKline withdrew all regulatory approval applications for a drug designed to cut men's risk of developing prostate cancer.

03/22/2011 - 10:13am

Cephalon plans to acquire a privately owned company developing treatments for cancer, Cephalon said Monday.